This inventor holds 1 USPTO granted patent. Top assignee: Metabolon, Inc.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Imran A Shah: Innovator in Hepatic Drug Response
Introduction
Imran A Shah is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of drug metabolism and toxicity. His work focuses on the development of biomarkers that can predict metabolic responses to hepatic drugs.
Latest Patents
Imran A Shah holds a patent titled "Biomarkers of metabolic responses to hepatic drugs." This patent outlines methods for measuring and predicting responses to hepatotoxicants and carcinogens through the detection of metabolites in mammals. The metabolites identified can serve as biomarkers, including efficacy biomarkers, surrogate biomarkers, and toxicity biomarkers. These methods are crucial for early prediction of toxicity, target identification and validation, and monitoring drug efficacy.
Career Highlights
Imran A Shah is currently employed at Metabolon, Inc., where he continues to advance research in metabolic responses. His work has implications for improving drug safety and efficacy, making a significant impact in the pharmaceutical industry.
Collaborations
One of his notable coworkers is Alvin Berger, with whom he collaborates on various research projects related to drug metabolism and toxicity.
Conclusion
Imran A Shah's innovative work in the field of hepatic drug responses and biomarkers positions him as a key figure in advancing drug safety and efficacy. His contributions are vital for the future of pharmacology and toxicology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile